Signature Resources Capital Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Signature Resources Capital Management, LLC
- $165 Billion
- Q2 2025
A detailed history of Signature Resources Capital Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Signature Resources Capital Management, LLC holds 180 shares of ARWR stock, worth $2,955. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 180
-0.0%
Holding current value
$2,955
Previous $2.29 Million
24.03%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
302Shares Held
97.3MCall Options Held
306KPut Options Held
432K-
Black Rock Inc. New York, NY15.7MShares$258 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$217 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$182 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$115 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$85.9 Million1.32% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.74B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...